H05BX02 - search results

zemplar 1 microgram

abbvie biopharmaceuticals ltd, israel - paricalcitol - capsules soft - paricalcitol 1 mcg - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.

Israel - English - Ministry of Health

zemplar 5 mcgml solution for injection

abbvie biopharmaceuticals ltd, israel - paricalcitol - solution for injection - paricalcitol 5 mcg/ml - paricalcitol - paricalcitol - paricalcitol is indicated for the prevention and treatment of secondary hyperparathyrodism associated with chronic renal failure.

Israel - English - Ministry of Health

zemplar 1 microgram

abbvie biopharmaceuticals ltd, israel - paricalcitol - capsules - paricalcitol 1 mcg - paricalcitol - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.

Ireland - English - HPRA (Health Products Regulatory Authority)

paricalcitol

medice arzneimittel putter gmbh & co. k.g - paricalcitol - solution for injection - 5 microgram/ml - paricalcitol - other anti-parathyroid agents - it is indicated for the prevention and treatment of secondary hyperparathyroidism in patients with chronic renal failure undergoing haemodialysis.

Ireland - English - HPRA (Health Products Regulatory Authority)

paricalcitol

medice arzneimittel putter gmbh & co. k.g - paricalcitol - solution for injection - 2 microgram/ml - paricalcitol - other anti-parathyroid agents - it is indicated for the prevention and treatment of secondary hyperparathyroidism in patients with chronic renal failure undergoing haemodialysis